IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hard to Treat Diseases Inc (HTDS)

CUSIP: 41164A103 | NYSE | 8 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Smith Chas P & Associates PA Cpas1,495,360
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Smith Chas P & Associates PA Cpas
1,495,360$00.0%CoreVery LowLakeland, FL2023-07-31